Proteomics International will be showcasing PromarkerD at the 58th ERA-EDTA Congress, Europe’s leading conference for kidney health from 5th–8th of June 2021. Intended to be a hybrid conference based both virtually and in Berlin, due to the global pandemic the Congress is now fully virtual. Approximately 5,000 nephrologists, transplantation experts and global healthcare leaders meet each year at the ERA-EDTA Congress to network and learn about the latest advances in kidney health treatment and technology.
PromarkerD can predict Diabetic Kidney Disease (DKD) up to 4 years before symptoms present. A simple test measures 3 plasma biomarkers and 3 clinical factors.
The European Renal Association and European Dialysis and Transplant Association (ERA-EDTA) is an organisation focused on advancing education and continuous professional development by utilising novel technology tools and established knowledge in the field in all areas of nephrology, from clinical nephrology to dialysis and transplantation, as well as enhancing the attention on chronic kidney disease as a public health priority.
Their mission is the advancement of medical science by promoting fundamental and clinical advances in the field of nephrology, dialysis, renal transplantation, hypertension, and related subjects.